ChemicalBook >> CAS DataBase List >>Ethanone, 2-[[(1R,2S)-2-[3,5-difluoro-2-(phenylmethoxy)phenyl]cyclopropyl]amino]-1-(4-methyl-1-piperazinyl)-, hydrochloride (1:1), rel-

Ethanone, 2-[[(1R,2S)-2-[3,5-difluoro-2-(phenylmethoxy)phenyl]cyclopropyl]amino]-1-(4-methyl-1-piperazinyl)-, hydrochloride (1:1), rel-

CAS No.
2262488-39-9
Chemical Name:
Ethanone, 2-[[(1R,2S)-2-[3,5-difluoro-2-(phenylmethoxy)phenyl]cyclopropyl]amino]-1-(4-methyl-1-piperazinyl)-, hydrochloride (1:1), rel-
Synonyms
S2157;Ethanone, 2-[[(1R,2S)-2-[3,5-difluoro-2-(phenylmethoxy)phenyl]cyclopropyl]amino]-1-(4-methyl-1-piperazinyl)-, hydrochloride (1:1), rel-
CBNumber:
CB311015737
Molecular Formula:
C23H28ClF2N3O2
Molecular Weight:
451.94
MDL Number:
MOL File:
2262488-39-9.mol
Last updated:2024-07-02 08:55:04

Ethanone, 2-[[(1R,2S)-2-[3,5-difluoro-2-(phenylmethoxy)phenyl]cyclopropyl]amino]-1-(4-methyl-1-piperazinyl)-, hydrochloride (1:1), rel- Properties

storage temp. Store at -20°C
form Solid
color White to off-white

Ethanone, 2-[[(1R,2S)-2-[3,5-difluoro-2-(phenylmethoxy)phenyl]cyclopropyl]amino]-1-(4-methyl-1-piperazinyl)-, hydrochloride (1:1), rel- Chemical Properties,Uses,Production

Biological Activity

S2157, a N-alkylated tranylcypromine (TCP) derivative, is a potent lysine-specific demethylase 1 (LSD1) inhibitor. S2157 increases H3K9 methylation and reciprocal H3K27 deacetylation at super-enhancer regions. S2157 induces apoptosis in TCP-resistant T-cell acute lymphoblastic leukemia (T-ALL) cells by repressing transcription of the NOTCH3 and TAL1 genes. S2157 efficiently pass through the blood-brain barrier and can almost completely eradicate CNS leukemia in mice transplanted with T-ALL cells[1]. S2157 is particularly effective for T-ALL cell lines with the IC50 values between 1.1 μM for human T-ALL cell lines CEM and 6.8 μM for MOLT4[1]. S2157 (4-20 μM; 72 hours) modestly inhibits mitogen-activated normal T-lymphocytes[1]. S2157 (4-8 μM; 24 hours) induces apoptosis and down-regulates the expression of NOTCH3 and TAL1 proteins in T-cell acute lymphoblastic leukemia (T-ALL) cells[1]. S2157 (50 mg/kg; IP; 3 times a week; for 28 days) causes the size of subcutaneous tumors reduced to less than 20% of that in the untreated control[1]. S2157 (50 mg/kg; IP) has a T1/2 of 0.88 hours, a Cmax of 4.33 μM and an AUC of 5.75 μM?h[1]. S2157 (30 mg/kg or 50 mg/kg; twice a week for 3 weeks) almost completely suppressed the growth of MOLT4 cells in most but not all NOD/SCID mice with MOLT4 cells. S2157 eradicates CNS leukemia in murine xenotransplanted models[1].

References

[1]. Shiori Saito, et al. Eradication of Central Nervous System Leukemia of T-Cell Origin With a Brain-Permeable LSD1 Inhibitor. Clin Cancer Res. 2019 Mar 1;25(5):1601-1611.

Ethanone, 2-[[(1R,2S)-2-[3,5-difluoro-2-(phenylmethoxy)phenyl]cyclopropyl]amino]-1-(4-methyl-1-piperazinyl)-, hydrochloride (1:1), rel- Preparation Products And Raw materials

Raw materials

Preparation Products

Ethanone, 2-[[(1R,2S)-2-[3,5-difluoro-2-(phenylmethoxy)phenyl]cyclopropyl]amino]-1-(4-methyl-1-piperazinyl)-, hydrochloride (1:1), rel- Suppliers

Global( 2)Suppliers
Supplier Tel Email Country ProdList Advantage
Shanghai Yifei Biotechnology Co. , Ltd. 021-65675885 18964387627 customer_service@efebio.com China 11974 58
TargetMol Chemicals Inc. 15002134094 marketing@targetmol.cn China 19711 58
Ethanone, 2-[[(1R,2S)-2-[3,5-difluoro-2-(phenylmethoxy)phenyl]cyclopropyl]amino]-1-(4-methyl-1-piperazinyl)-, hydrochloride (1:1), rel- S2157 2262488-39-9 C23H28ClF2N3O2